Robert Lenk
Direktor/Vorstandsmitglied bei PLUS THERAPEUTICS, INC.
Vermögen: 48 829 $ am 30.04.2024
Aktive Positionen von Robert Lenk
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.03.2020 | - |
| Independent Dir/Board Member | 01.03.2020 | - | |
Houston Partners
 Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
| Lenk Pharmaceuticals, LLC | Präsident | 01.01.2016 | - |
POP Biotechnologies, Inc.
 POP Biotechnologies, Inc. BiotechnologyHealth Technology POP Biotechnologies, Inc. is a biotechnology company. The private company is based in Buffalo, NY. The company was founded in 2015 by Jonathan Lovell, Jonathan Smyth, Kevin Carter. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Robert Lenk
Ehemalige bekannte Positionen von Robert Lenk
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MediVector, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | 01.01.2016 |
| LUNA INNOVATIONS INCORPORATED | Corporate Officer/Principal | 01.01.2004 | 15.04.2010 |
| Therapeutics 2000, Inc. | Vorstandsvorsitzender | 01.01.1995 | 01.09.2003 |
| Präsident | 01.01.1995 | 01.09.2003 | |
| Argus Pharmaceuticals, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1989 | - |
| Gründer | 01.01.1989 | - | |
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Gründer | 01.01.1981 | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Robert Lenk
| Massachusetts Institute of Technology | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 12 |
Operativ
| President | 3 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
Sektoral
| Health Technology | 5 |
| Finance | 3 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LUNA INNOVATIONS INCORPORATED | Electronic Technology |
| PLUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
| Argus Pharmaceuticals, Inc. | Health Technology |
Houston Partners
Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Finance |
| MediVector, Inc. | |
| OncoVector, Inc. | |
| Therapeutics 2000, Inc. | |
| Lenk Pharmaceuticals, LLC | |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology POP Biotechnologies, Inc. is a biotechnology company. The private company is based in Buffalo, NY. The company was founded in 2015 by Jonathan Lovell, Jonathan Smyth, Kevin Carter. | Health Technology |
- Börse
- Insiders
- Robert Lenk
- Erfahrung
